Opinion

  • 01 December 2023
    Communities Affected by HIV Will Write the Last Chapter of the Disease

    By Dr. Vuyiseka Dubula, Head of Community Rights and Gender, the Global Fund

    Dramatic changes have shaped the fight against HIV in the last 20 years. Highly effective antiretroviral therapy existed at the turn of the millennium – but only in rich countries. For people living in low- and middle-income countries – like my home ...
  • 01 December 2023
    We Must Not Let Climate Change Derail The Fight Against Malaria

    By Peter Sands, Executive Director of the Global Fund to Fight AIDS, TB and Malaria

    The world is at a defining moment in the fight against malaria. After years of rapid advances against the disease, progress stalled around 2015. Since then, the malaria community has faced a cascade of challenges, including drug and insecticide resis...
  • 28 November 2023
    Climate Change Could Cause a Malaria Upsurge in Africa. We Need to Act
    The French association Élus Locaux Contre le Paludisme (ELCP) is sounding the alarm about the increased risk of malaria on the African continent due to climate change. The group is calling for international solidarity and urging France to step up its...
  • 17 November 2023
    As the Climate Crisis Escalates, Building Resilient Health Systems Is Imperative

    By Hon. Khumbize Kandodo Chiponda, MP, Minister of Health, Malawi

    When torrential rains from Cyclone Freddy unleashed a flood in Malawi earlier this year, the extreme weather event claimed more than 1,000 lives and upended the livelihoods of millions of people. The floods also swept away a wealth of essential healt...
  • 10 November 2023
    To Prevent the Next Pandemic, Follow the Science

    By Marisa Peyre, Co-founder and Global Science Adviser, PREZODE, Justin Vaïsse, Founder and Director General, Paris Peace Forum, and Peter Sands, Executive Director, The Global Fund

    The COVID-19 pandemic has underscored the critical role of evidence-based policies in addressing global health crises. It has also highlighted the need for flexible strategies, equitable health care, and multidisciplinary approaches that bridge the g...
  • 07 November 2023
    In the Fight to End Tuberculosis, This Is the Moment for Progress

    By Peter Sands, Executive Director, The Global Fund

    Tuberculosis is rarely in the spotlight. But behind the scenes it’s one of the top infectious killers in the world. In 2022 alone, TB killed over 1.3 million people, including 167,000 people with HIV — that’s a staggering 25,000 deaths every week. De...
  • 07 November 2023
    Taking a Smart Approach to Making Medicines in Africa Will Save Lives

    By Peter Sands, Executive Director, The Global Fund

    COVID-19 shone a harsh light on global health inequities. Africa was last in the queue for all the lifesaving tools needed to defeat the new virus, including vaccines, tests, oxygen and personal protective equipment. Yet this is not a new phenomenon...
  • 21 September 2023
    Stopping Malaria From Killing Children is a Matter of Urgency

    By Peter Sands, Executive Director, The Global Fund

    I was in Kano, an ancient city in the north of Nigeria recently, visiting health facilities with Nigeria’s impressive new health minister professor Muhammad Ali Pate. This week I’ll be in New York, along with the leaders of nearly 200 countries and m...
  • 19 September 2023
    For the Fight Against HIV, TB and Malaria, a Moment of Reckoning

    By Peter Sands, Executive Director, The Global Fund

    The heads of state and government from nearly 200 countries gathering this week in New York for the United Nations General Assembly must confront the stark reality that the Sustainable Development Goals are in dire jeopardy. This year marks the midpo...
  • 29 August 2023
    India and the Global Fund: A strategic partnership with a national, regional, and global future

    By Lady Roslyn Morauta, Chair of the Board

    How the global fight against HIV, tuberculosis (TB), and malaria is an opportunity for India’s pharmaceutical industry and other private-sector companies.